Recall Record

Englewood, CO, United States

Denver Solutions, LLC DBA Leiters Health recalls

6 recalls recorded since 2018, most recently on 31 March 2025. 3 are listed as ongoing. Status and classification are as published by the FDA.

Recalls6
Ongoing (FDA)3
Terminated or completed3
Class I (FDA)1

Ongoing Class II Drugs

Recall started
31 March 2025
Reason
Lack of Assurance of Sterility: Leaking/damaged syringes.
Distribution
Nationwide in the U.S.A
Initiated
Voluntary: Firm initiated
Recall numbers
D-0374-2025, D-0371-2025, D-0370-2025, D-0373-2025, D-0372-2025

Ongoing Class II Drugs

Recall started
20 February 2024
Reason
Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.
Distribution
Nationwide in the USA
Initiated
Voluntary: Firm initiated
Recall numbers
D-0362-2024, D-0363-2024, D-0361-2024

Ongoing Class I Drugs

Recall started
28 December 2023
Reason
Superpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.
Distribution
Nationwide within the United States
Initiated
Voluntary: Firm initiated
Recall numbers
D-0281-2024, D-0277-2024, D-0282-2024, D-0278-2024, D-0279-2024, D-0280-2024

Terminated Class III Drugs

Recall started
4 October 2023
Terminated
15 August 2024
Reason
Labeling: Not Elsewhere Classified
Distribution
USA Nationwide
Initiated
Voluntary: Firm initiated
Recall numbers
D-0071-2024, D-0072-2024, D-0070-2024

Terminated Class II Drugs

Recall started
21 February 2023
Terminated
11 January 2024
Reason
CGMP DEVIATIONS
Distribution
Nationwide within the United States including VA or other Government facilities
Initiated
Voluntary: Firm initiated
Recall numbers
D-0444-2023, D-0442-2023, D-0443-2023, D-0445-2023

Terminated Class II Drugs

Recall started
29 November 2021
Terminated
12 July 2022
Reason
Labeling: Label Mix-up: Vials labeled as moxifloxacin 1 mg/mL may actually contain moxifloxacin 5 mg/mL
Distribution
Nationwide within the United States
Initiated
Voluntary: Firm initiated
Recall number
D-0288-2022

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.